$2.5M Philly Risperdal Verdict Against J&J Will Stay Put

Law360, New York (May 10, 2016, 7:03 PM EDT) -- A Philadelphia judge has refused to disturb a $2.5 million jury verdict against a Johnson & Johnson unit over allegations its antipsychotic drug Risperdal caused an autistic boy to grow breasts, denying retrial bids from both sides of the dispute.

In a May 4 order, Philadelphia County Court of Common Pleas Judge Ramy I. Djerassi rejected Janssen Pharmaceuticals Inc.'s argument that letting in a new expert during the bellwether trial had prejudiced the drugmaker. The judge also refused the now 20-year-old Austin Pledger and his mother a new trial exclusively on Janssen's punitive liability and damages.

Janssen had argued that the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!